POLYMED

Poly Medicure Financial Results

₹1,625.00-0.54%
Market cap
₹16,471 crore
P/E
52.5
P/B
5.30
ROE
11.3%
Dividend yield
0.22%

For the year ended Mar 2019, Poly Medicure reported revenue of ₹611 crore and net profit of ₹65 crore, against ₹687 crore and ₹96 crore a year earlier.

Poly Medicure annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Poly Medicure annual profit and loss (₹ crore)
ItemMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue611687786—1,1091,3661,6701,8751,997
Expenses481523572—8341,0001,2161,4331,693
Operating profit129164214—275366453442305
Operating margin %21%24%27%—25%27%27%24%15%
Other income201818—285294119267
Interest12189—911121822
Depreciation374148—576383116128
Profit before tax100124177—237344453427422
Tax %35%24%25%—25%25%25%22%26%
Net profit6596136—179258339331313
EPS (₹)0.000.0014.16—18.6926.9133.4132.6830.96
Dividend payout %—————————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Poly Medicure financial results — frequently asked questions

What is Poly Medicure's annual revenue and net profit?

For the financial year ended Mar 2019, Poly Medicure's revenue was ₹611 crore and net profit ₹65 crore; net profit fell 32.29% from ₹96 crore in Mar 2020.

What is the EPS of Poly Medicure?

Annual EPS for Mar 2019 was ₹0.00.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Poly Medicure With ATS

Track POLYMED live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.